PRICE T ROWE ASSOCIATES INC /MD/ - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 168 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$465
-99.9%
15,893
+6.8%
0.00%
Q3 2022$393,000
-8.2%
14,875
+54.2%
0.00%
Q2 2022$428,000
-34.0%
9,644
-26.3%
0.00%
Q1 2022$648,000
-4.1%
13,088
-1.3%
0.00%
Q4 2021$676,000
-10.1%
13,267
-1.5%
0.00%
Q3 2021$752,000
+30.3%
13,475
-0.1%
0.00%
Q2 2021$577,000
-8.1%
13,485
-10.3%
0.00%
Q1 2021$628,000
-32.0%
15,039
-24.2%
0.00%
Q4 2020$924,000
-16.2%
19,840
-23.5%
0.00%
Q3 2020$1,102,000
+22.3%
25,943
+38.1%
0.00%
Q2 2020$901,000
-3.2%
18,787
-7.2%
0.00%
Q1 2020$931,000
-1.8%
20,236
+28.3%
0.00%
Q4 2019$948,000
+9.7%
15,772
+3.3%
0.00%
Q3 2019$864,000
+3.3%
15,272
+1.7%
0.00%
Q2 2019$836,000
+10.4%
15,022
+0.1%
0.00%
Q1 2019$757,000
+25.7%
15,002
+0.4%
0.00%
Q4 2018$602,000
-33.8%
14,948
+13.8%
0.00%
Q3 2018$910,000
+33.4%
13,130
+45.7%
0.00%
Q2 2018$682,000
+44.2%
9,009
+0.4%
0.00%
Q1 2018$473,000
-0.6%
8,972
+0.8%
0.00%
Q4 2017$476,000
-75.2%
8,904
-72.3%
0.00%
Q3 2017$1,917,000
-52.7%
32,138
-37.4%
0.00%
-100.0%
Q2 2017$4,052,000
+691.4%
51,365
+732.6%
0.00%
Q1 2017$512,000
-42.2%
6,169
-44.8%
0.00%
Q4 2016$886,000
+34.7%
11,169
+18.8%
0.00%
Q3 2016$658,0009,4050.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 113,737$3,2270.98%
Smith, Graham & Co., Investment Advisors, LP 236,883$6,720,3710.82%
Capital Impact Advisors, LLC 13,607$386,0310.47%
TANG CAPITAL MANAGEMENT LLC 80,000$2,269,6000.34%
BRANDES INVESTMENT PARTNERS, LP 545,050$15,463,0690.33%
Watershed Asset Management, L.L.C. 9,496$269,4020.33%
Jackson Creek Investment Advisors LLC 25,164$7140.30%
SummerHaven Investment Management, LLC 18,178$515,7100.30%
Virtus Fund Advisers, LLC 1,117$31,6890.22%
Virtus Investment Advisers, Inc. 7,308$207,3280.14%
View complete list of EAGLE PHARMACEUTICALS INC shareholders